Stonepine Capital Management’s Kezar Life Sciences KZR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$778K	Buy	169,859 +69,859	+70%	+$320K	0.76%	32
2025 Q1	$488K	Sell	100,000 -10,000	-9%	-$48.8K	0.47%	39
2024 Q4	$739K	Sell	110,000 -39,131	-26%	-$263K	0.6%	34
2024 Q3	$1.15M	Buy	149,131 +44,086	+42%	+$341K	0.73%	26
2024 Q2	$630K	Buy	+105,045	New	+$630K	0.58%	20